Medicenna Therapeutics Corp's total assets for Q3 2024 were C$32.24M, a decrease of -2.10% from the previous quarter. TSE:MDNA total liabilities were C$14.79M for the fiscal quarter, a 14.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.